MEDfarms of Michigan Secures $6 Million in Non-Dilutive Debt Capital

MEDfarms LLC secured an ABL credit facility to strengthen its balance sheet and increase the company’s market share in its award-winning cannabis products.

According to Brandon Dabish, Founder and CEO, “With this funding, we will continue to expand our culture, cGMP processing, outlets and add staff to accelerate growth in 2022.”

—Brandon Dabish

FORT LAUDERDALE, FLORIDA, USA, January 12, 2022 /EINPresswire.com/ — MEDfarms of Michigan secures $6 million in non-dilutive debt capital.

MEDfarms LLC, One of Michigan’s Leading Vertically Integrated Operators, Secured Senior Contract credit facility to strengthen its balance sheet and increase the company’s market share for its award-winning premium cannabis products. According to Brandon Dabish, Founder and CEO, “With this funding, we will continue to grow our culture, cGMP processing, open additional outlets and add staff to accelerate growth in 2022.”

Highway 33 Capital, an investment banking advisory boutique, was instrumental in the transaction, helping assess MEDFarms’ finances before preparing due diligence documents for underwriters’ review and negotiating terms. This simplified the process and allowed MEDfarms to secure competitive debt financing terms for their vertical licensed cannabis company.

According to Managing Partner David Hofer, “Recent multi-million dollar debt financing among cannabis industry leaders shows that debt as a source of capital for cannabis companies is a rational use of capital – potentially cleaning up balance sheets and providing access to financing for expansion and/or the acquisition of distressed assets.

About MEDfarms
Having doubled its revenue every year since its inception in 2018, MEDfarms has become one of the leading vertically integrated operators in Michigan with a range of award-winning medical and recreational cannabis products in high demand across its 4 supply centers in wholly owned and in more than 150 retail outlets. outlets throughout the state.

About Highway 33 Capital Advisory
With offices in Miami, Denver, Detroit and San Francisco, Highway 33 is a boutique investment banking advisory specializing in preparing companies for highly regulated markets – Cannabis, Healthtech, Biotech, Pharma, Clean/Climatetech, CBD /Hemp, as well as ancillary technologies like SaaS businesses – which seek to drive business growth and valuations through mergers and acquisitions, non-dilutive debt financing and/or equity investments.

For more information, contact [email protected]

David Hoffer
Highway 33 Capital Notice
write us here

Comments are closed.